KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 1 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $1,000 | -66.7% | 168 | -66.5% | 0.00% | – |
Q2 2016 | $3,000 | +50.0% | 501 | -3.8% | 0.00% | – |
Q1 2016 | $2,000 | -33.3% | 521 | +3.6% | 0.00% | – |
Q4 2015 | $3,000 | +50.0% | 503 | 0.0% | 0.00% | – |
Q3 2015 | $2,000 | -71.4% | 503 | -25.0% | 0.00% | – |
Q2 2015 | $7,000 | +40.0% | 671 | +68.2% | 0.00% | – |
Q1 2015 | $5,000 | +25.0% | 399 | +51.1% | 0.00% | – |
Q4 2014 | $4,000 | -86.7% | 264 | -87.8% | 0.00% | – |
Q3 2014 | $30,000 | +650.0% | 2,164 | +719.7% | 0.00% | – |
Q2 2014 | $4,000 | -73.3% | 264 | -70.3% | 0.00% | – |
Q1 2014 | $15,000 | – | 889 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |